China Registry Study on Extracorporeal Membrane Oxygenation ECMO Support for Heart and Lung Failure Patients

What this Trial Is About

Extracorporeal life support ECLS, also called extracorporeal membrane oxygenation ECMO, is a technique that helps support the heart and lungs in patients with heart failure, lung failure, or both. In China, the use of ECLS has grown over the past decade, with more cases and more centers adopting this technology. This multi-center registry study, led by the Chinese Society of Extracorporeal Life Support, aims to collect data on the use of ECLS in China and evaluate both short-term and long-term patient outcomes. The study includes patients receiving ECMO for different conditions such as acute respiratory failure, acute respiratory distress syndrome ARDS, heart failure, cardiogenic shock, and cardiac arrest. Data are collected from multiple hospitals across China to capture real-world use of ECMO as a device providing circulatory and respiratory support. Different groups in the registry represent pulmonary support, cardiac support, and extracorporeal cardiopulmonary resuscitation. Participants in the study have their health outcomes observed and recorded, including 30-day and 365-day all-cause mortality, rates of successful ECMO weaning, ECMO-related and other complications, and length of stay in intensive care units and hospitals. This observational study monitors these measures to better understand the effects and outcomes associated with ECMO treatment over time. The study began in 2017 and is planned to continue through 2030.

China Extracorporeal Life Support Registry